BYAH
Park Ha Biological Technology Co., Ltd. Ordinary Shares
NASDAQ · Consumer Cyclical · Personal Products & Services · CN
$2.52
−4.55%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-70.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 7, 2026 | Zhu Xiaoyan · officer: CFO | A-Award | 112,500 | $0.18 |
Institutional positioning
13F filings over the trailing two quarters
New 3Increased 0Reduced 0Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| UBS GROUP AG | New Position | 80 | May 5, 2026 |
| MORGAN STANLEY | New Position | 16 | May 15, 2026 |
| ROYAL BANK OF CANADA | New Position | 1 | May 15, 2026 |
| ROYAL BANK OF CANADA | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 7, 2026